| Date | Speaker | Title | Time starts | Duration |
| November 2015 | Chris Kosmidis | Isavuconazole: a new antifungal drug | 0’00’00secs | 0’36’40secs |
| Graham Atherton | Patients and carers disucssion | 0’36’40secs | end | |
| Led by Graham Atherton | Entire meeting (alternate version) |
We had to switch off the discussion with patients after Chris & Graham’s introduction ending at 36min 40sec as the group had to proceed privately. The slides discussed give a good deal of the information we talked about so are well worth reading once the talking has stopped.
Resources mentioned:
Share this post
Latest News posts
The Benefits of Peer Support
March 25, 2023
2023 Bronchiectasis Patient Conference
March 23, 2023
Fungal vaccine developments
March 22, 2023
Asthma UK’s End the Lung Health Lottery
March 21, 2023
Secondary Adrenal Insufficiency
March 17, 2023
IgG and IgE explained
March 14, 2023
News archive
× Close
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video